GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Biovica International BIOVIC B.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.32

+1.92%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2026

Revenue

SEK 13.4m

FY2017FY2026

Net income

−SEK 69.9m

FY2017FY2026

Free cash flow

−SEK 63.3m

FY2017FY2026

Shareholders' equity

SEK 86.3m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueSEK 13.4mSEK 8.6mSEK 7.3mSEK 3.4mSEK 2.0mSEK 2.1mSEK 1.7mSEK 3.0mSEK 2.7mSEK 632,000
Research and development——SEK 5.1mSEK 5.3mSEK 13.0mSEK 7.6mSEK 2.6mSEK 1.5mSEK 1.3mSEK 1.3m
Operating income−SEK 70.0m−SEK 85.1m−SEK 126.8m−SEK 110.4m−SEK 60.1m−SEK 40.2m−SEK 29.8m−SEK 21.7m−SEK 18.0m−SEK 14.8m
Net income−SEK 69.9m−SEK 87.6m−SEK 124.8m−SEK 110.5m−SEK 60.0m−SEK 39.5m−SEK 30.3m−SEK 21.6m−SEK 18.1m−SEK 14.9m
Diluted earnings per share-0.24-0.30-1.37-2.27-1.95-1.31-1.02-0.87-0.99-0.82

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsSEK 107.7mSEK 64.9mSEK 131.4mSEK 172.3mSEK 151.6mSEK 192.7mSEK 90.3mSEK 60.9mSEK 80.8mSEK 97.2m
Cash and short-term investmentsSEK 70.4mSEK 24.4mSEK 79.4mSEK 114.3mSEK 89.8mSEK 145.4mSEK 40.8mSEK 16.8mSEK 42.1mSEK 65.4m
Total liabilitiesSEK 21.4mSEK 21.7mSEK 34.8mSEK 33.7mSEK 27.5mSEK 10.0mSEK 12.0mSEK 8.8mSEK 7.1mSEK 5.6m
DebtSEK 4.3mSEK 4.7mSEK 7.8mSEK 10.5mSEK 13.2mSEK 2.4mSEK 3.5mSEK 3.6m−SEK 3.0m−SEK 2.0m
Shareholders' equitySEK 86.3mSEK 43.2mSEK 96.6mSEK 138.6mSEK 124.1mSEK 182.7mSEK 78.2mSEK 52.1mSEK 73.7mSEK 91.5m
Shares outstanding292m292m91m49m31m30m30m25m18m18m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−SEK 62.8m−SEK 85.4m−SEK 114.6m−SEK 94.6m−SEK 52.1m−SEK 34.4m−SEK 24.8m−SEK 18.0m−SEK 14.9m−SEK 11.1m
Capital spending−SEK 474,000−SEK 287,000−SEK 146,000−SEK 2.8m−SEK 3.4m−SEK 3.6m−SEK 7.0m−SEK 7.3m−SEK 8.6m−SEK 5.8m
Free cash flow−SEK 63.3m−SEK 85.7m−SEK 114.7m−SEK 97.4m−SEK 55.5m−SEK 38.0m−SEK 31.8m−SEK 25.3m−SEK 23.5m−SEK 16.9m

Latest quarters

By quarter end

Jul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024
RevenueSEK 4.0mSEK 4.8mSEK 3.3mSEK 2.7mSEK 2.6mSEK 2.3mSEK 2.3mSEK 2.3m
Operating income−SEK 20.4m−SEK 18.1m−SEK 17.8m−SEK 15.0m−SEK 19.3m−SEK 20.3m−SEK 22.2m−SEK 19.8m
Net income−SEK 20.1m−SEK 19.1m−SEK 17.9m−SEK 15.1m−SEK 17.8m−SEK 20.8m−SEK 22.8m−SEK 21.2m
Diluted earnings per share-0.07-0.07-0.06-0.05-0.06-0.07-0.08-0.23
Cash from operations−SEK 16.0m−SEK 15.0m−SEK 11.0m−SEK 18.0m−SEK 17.0m−SEK 17.0m−SEK 17.0m−SEK 21.0m
Capital spending−SEK 1.0m———————
Free cash flow−SEK 17.0m———————
Total assetsSEK 90.1mSEK 107.7mSEK 126.5mSEK 138.6mSEK 56.8mSEK 64.9mSEK 86.9mSEK 108.4m
Cash and short-term investmentsSEK 51.6mSEK 70.4mSEK 88.2mSEK 100.7mSEK 16.3mSEK 24.4mSEK 43.5mSEK 61.9m
DebtSEK 3.0mSEK 2.5mSEK 4.8mSEK 3.0mSEK 13.9mSEK 4.7mSEK 6.1mSEK 6.9m
Shareholders' equitySEK 66.6mSEK 86.3mSEK 105.9mSEK 123.8mSEK 25.7mSEK 43.2mSEK 64.5mSEK 86.9m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue58.1%45.1%18.6%
Operating income-14.1%11.8%31.3%
Net income-14.2%12.1%30.1%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-705.1%-1200.9%-1338.9%-1230.6%
Net margin-715.9%-1202.2%-1337.9%-1231.8%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-1.4-1.2-1.5-1.1-2.0-14.7-23.3-6.3-3.9-6.6
Price to sales7.112.524.937.157.6278.8422.845.126.1154.4

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.